АСПЕКТЫ СИНДРОМА САРКОПЕНИИ В ОНКОЛОГИЧЕСКОЙ ПРАКТИКИ: ДИАГНОСТИКА И ЛЕЧЕНИЕ (ЛИТЕРАТУРНЫЙ ОБЗОР)
Ключевые слова:
саркопения, скелетная мускулатура, химиотерапия, парентеральное питаниеАннотация
Саркопения диагностируется у 20-70% пациентов с распространенными новообразованиями и связана с рядом негативных последствий. В то же время это состояние редко попадает в центр внимания практикующих онкологов, в том числе из-за трудностей диагностики. Коррекция саркопении требует мультидисциплинарного подхода: включая оптимальное питание с потреблением достаточного количества белка, микроэлементов, а также аэробные и силовые физические нагрузки.
Библиографические ссылки
Руководство по клиническому питанию. Под ред. В.М. Луфта, Санкт-Петербург, 2016, 484 с. 4.
Baracos VE, Relman T, Mourtzakis M, et al. Body composition in patients with nonsmall lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am. J. Clin. Nutr. 2010; 91 (4): 1133S-1137S. 5.
Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev. Endocr. Metab. Disord. 2012; 13: 71–77. 6.
Chapman I. Weight loss in older persons. Medical clinics of North America. 2011; 95 (3): 579–93. 7.
Cho KM, Park H, Oh DY, et al. Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy.Oncotarget.2017; 8 (45): 79441–79452. 8.
Choi Y, Oh DY, Kim TY. Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy. Independent of BMI. PLoS One. 2015; 10 (10): e0139749. 9.
Cruz-Jentoft A. J., Baeyens J.P., Bauer J.M. et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010; 39 (4): 412–23. 10.
Cushen SJ, Power DG, Ryan A.M, Nutrition assessment in oncology. Top. Clin. Nutr. 2015; 30 (1): 103–19. 11.
Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mTOR signaling and human skeletal muscle protein synthesis. Curr. Opin. Clin. Nutr. Metab. Care. 2008; 11: 222–226. 12.
Ferrando AA, Sheffield-Moore M, Yeckel CW, et al. Testosterone administration to older man improves muscle function: molecular and physiological mechanisms. Am.J. Physiol Endocrinol Metab. 2002; 282: E601–607. 13.
Ferrucci L, Penninx BW, Volpano S, et al. Change in muscle strength explains accelerated decline oh physical function in older women with high IL-6 serum levels. J. Am. Geriatr, Soc. 2002; 50: 1947–1954. 14.
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosis condition in older adults — current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J. Am. Med. Dir. Assoc. 2011; 12: 249–256. 15.
Gonzales MC, Pastore CA, Orlandi SP, et al. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014; 99: 999–1005. 16.
Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength in the elderly: the health ABC study. J. Appl. Physiol. 2001; 90: 2157–2165. 17.
Jansen I, Shepard DS., Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004; 52: 80–85. 18.
Kovacheva EL, Hikim AP, Shen R, et al. Testosterone supplementation reverses sarcopenia in aging through regulation of myoststin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways. Endocrinology. 2010; 151: 628–638. 19.
Kubrak C, Olson K, Jha N, et al. Clinical determinants of weight loss in patients receiving radiation and chemoradiation for head and neck cancer: A prospective longitudinal view. Head Neck. 2013; 35: P. 695–703. 20.
Kurk S.A, Peeters P.H.M., Dorresteijn B, et al. Evolution of skeletal muscle mass (SMM) during palliative systemic in metastatic colorectal cancer (mCRC) patients participating in the randomized phase 3 CAIRO3 study // Abstract ESMO 2016. Copenhagen, Denmark, 2016. 21.
Malafarina V, Uriz-Otano F, Iniesta R, et al. Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas.2012; 71: 109–114. 22.
Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J. Am. Med. Dir. Assoc. 2013; 14 (8): 531–553. 23.
Martin L., Birdsell L., Macdonald N., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol, 2013; 31 (12): 1539–1547. 24.
Melton LJ, 3rd. Khosla S, Crowson CS. Epidemiology of sarcopenia. J. Am. Geriatr, Soc. 2000; 48: 625–630. 25.
Messinger-Rapport В, Thomas D., Gammack H., et al. Clinical update on nursing home medicine: 2009. J. Am. Med. Dir. Association. 2009; 10: 530–53. 26.
Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: An authentic strength preserving hormone. Mol. Aspects. Med. 2005. 26; 203–219. 27.
Morley JE, Argiles JM, Evans WJ, et al. Society for Sarcopenia, Cachexia, Wasting Disease. Nutritional recommendations for the management of sarcopenia. J. Am. Med. Dir. Association. 2010; 11: 391–396. 28.
Muller MJ, Wang Z, Heymsfield SB, et al. Advances in the understanding of specific metabolic rates of major organs and tissues in humans. Curr. Opin. Clin. Nutr. Metab. Care. 2013; 16: 501–508. 29.
Muscaritoli M., Anker S.D., Argiles J. et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) «cachexia-anorexia in chronic wasting diseases» and «nutrition in geriatrics». Clin. Nutr. 2010. Vol. 29, № 2. P. 154–159. 30.
Philippou A, Maridaki M, Halapas A, et al. The role of the insulin-like growth factor-I (IGF-I) in skeletal muscle physiology. In Vivo. 2007; 21:45–54. 31.
Prado CM, Baracos VE, McCargar LJ, et al. Body composition as an independent determinant of 5-fluoracil-based chemotherapy toxicity. Clin. Cancer.Res. 2007; 13 (1). 3264–3268. 32.
Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients solid tumours of the respiratory and gastrointestinal tracts: a population- based study. Lancet Oncol. 2008; 29 (2). 154–159. 33.
Prado CM, Antoun S, Sawyer MB. Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity. Curr. Opin. Clin. Nutr. Metab. Care. 2011; 14 (3): 250–254. 34.
Rakhimov M. Nodir, Khudayberdiyeva A. Shohista, Oripova R. Mehriniso, Shakhanova Sh. Shakhnoza. Practical recommendations forNutritional support for cervical cancer// Journal of Biomedicine and Practice. 2023, vol. 8, issue 2,pp.224-230
Rizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. Springer. 2013. DOI 10.1007/ s00223–013–9759-y. 35.
Rolland Y, Onder G, Morley J, et al. Current and future pharmacological treatment of sarcopenia. Clinics in Geriatric Medicine. 2011; 27: 423–447. 36.
Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin. Geriatr. Med. 2011; 27. 337– 339. 37.
Roubenoff, Hughes VA. Sarcopenia: current concepts. J. Gerontol. A. Biol. Sci Med. Sci. 2000; 55: M716-M724. 38.
Sakuma K., Yamaguchi A. Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci. 2010; 3: 90–101. 39.
Scott D., Blizzard L., Fell J, et al. The epidemiology sarcopenia in community living older adults: what role does lifestyle play? J. Cachexia. Sarcopenia. Muscle 2010; 2: 125–134. 40.
Shachar S, Williams G, Muss H, Nishijima T. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer. 2016 Apr; 57: 58–67. doi: 10.1016/j.ejca.2015.12.030. Epub 2016 Feb 13. Review. 41.
Sharma P, Zargar-Shoshtari K, Caracciolo JT, Fishman M, Poch MA, Pow-Sang J, Sexton WJ, Spiess PE. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Urol. Oncol. 2015; 33: 339.e17–23. 42.
Short KR, Nair KS. The effect of age on protein metabolism. Curr. Opin. Clin. Nutr. Metab. Care. 2000; 3: 39–44. 43.
Short KR, Vittone JL, Bigelow JL.et al. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am.J. Physiol. Endocrinol. Metab. 2004; 286: E92-E101. 44.
Sinha-Hikim I, Cornford M, Gaytan H, et al. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older man. J. Clin. Endocrinol. Metab. 2006; 91: 3024–3033. 45.
Rizaev J. A., Maeda H., Khramova N. V. Plastic surgery for the defects in maxillofacial region after surgical resection of benign tumors //Annals of Cancer Research and Therapy. – 2019. – Т. 27. – №. 1. – С. 22-23.
Rizaev Jasur, Norbutayev Alisher, Murtazayev Alisher. Modern methods for detecting oral cavity defects in hemoblastosis, detecting the degree of damage and prediction of the clinical current. Journal of Biomedicine and Practice. 2021, vol. 6, issue 5, pp. 45-51
Alimjanovich, R. Z., Maxammatkulovich, R. N., & Khikmatovich, K. K. (2022). Age Features of the Prevalence of Prostate Cancer in Uzbekistan. Central Asian Journal of Medical and Natural Science, 3(5), 154-157. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/1062
